173 related articles for article (PubMed ID: 36907636)
1. Diagnosis and management of Hodgkin lymphoma in children, adolescents, and young adults.
Belsky JA; Hochberg J; Giulino-Roth L
Best Pract Res Clin Haematol; 2023 Mar; 36(1):101445. PubMed ID: 36907636
[TBL] [Abstract][Full Text] [Related]
2. AYA Considerations for Aggressive Lymphomas.
Llaurador G; Giulino-Roth L
Curr Hematol Malig Rep; 2021 Feb; 16(1):61-71. PubMed ID: 33728589
[TBL] [Abstract][Full Text] [Related]
3. Challenges and perspectives in the immunotherapy of Hodgkin lymphoma.
Michot JM; Lazarovici J; Ghez D; Danu A; Fermé C; Bigorgne A; Ribrag V; Marabelle A; Aspeslagh S
Eur J Cancer; 2017 Nov; 85():67-77. PubMed ID: 28892775
[TBL] [Abstract][Full Text] [Related]
4. Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment.
Hsi ED
Leuk Lymphoma; 2008 Sep; 49(9):1668-80. PubMed ID: 18798102
[TBL] [Abstract][Full Text] [Related]
5. Hodgkin lymphoma in children and adolescents: improving the therapeutic index.
Kelly KM
Hematology Am Soc Hematol Educ Program; 2015; 2015():514-21. PubMed ID: 26637767
[TBL] [Abstract][Full Text] [Related]
6. Hodgkin lymphoma in children and adolescents: improving the therapeutic index.
Kelly KM
Blood; 2015 Nov; 126(22):2452-8. PubMed ID: 26582374
[TBL] [Abstract][Full Text] [Related]
7. Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents.
Giulino-Roth L; Keller FG; Hodgson DC; Kelly KM
Br J Haematol; 2015 Jun; 169(5):647-60. PubMed ID: 25824371
[TBL] [Abstract][Full Text] [Related]
8. Moving things forward in Hodgkin lymphoma.
Bröckelmann PJ; Böll B
F1000Res; 2018; 7():. PubMed ID: 30473768
[TBL] [Abstract][Full Text] [Related]
9. Classic Hodgkin Lymphoma in Adolescents and Young Adults.
Kelly KM; Friedberg JW
J Clin Oncol; 2024 Feb; 42(6):653-664. PubMed ID: 37983570
[TBL] [Abstract][Full Text] [Related]
10. Standard therapies versus novel therapies in Hodgkin lymphoma.
Gallamini A; Di Raimondo F; La Nasa G; Romano A; Borra A; Greco M
Immunol Lett; 2013; 155(1-2):56-9. PubMed ID: 24140162
[TBL] [Abstract][Full Text] [Related]
11. The circuitry of the tumor microenvironment in adult and pediatric Hodgkin lymphoma: cellular composition, cytokine profile, EBV, and exosomes.
Nagpal P; Descalzi-Montoya DB; Lodhi N
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1311. PubMed ID: 33103852
[TBL] [Abstract][Full Text] [Related]
12. [Not Available].
Gilardin L; Amorim S; Bernard S; Ravdan O; Thieblemont C; Brice P
Bull Cancer; 2018 Dec; 105 Suppl 1():S50-S58. PubMed ID: 30595199
[TBL] [Abstract][Full Text] [Related]
13. [Hodgkin lymphoma: Current and future therapeutic strategies].
Turpin A; Michot JM; Kempf E; Mazeron R; Dartigues P; Terroir M; Boros A; Bonnetier S; Castilla-Llorente C; Coman T; Danu A; Ghez D; Pilorge S; Arfi-Rouche J; Dercle L; Soria JC; Carde P; Ribrag V; Fermé C; Lazarovici J
Bull Cancer; 2018 Jan; 105(1):81-98. PubMed ID: 29289336
[TBL] [Abstract][Full Text] [Related]
14. Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.
Zawati I; Adouni O; Finetti P; Manai M; Manai M; Gamoudi A; Birnbaum D; Bertucci F; Mezlini A
Cancer Radiother; 2020 Jun; 24(3):206-214. PubMed ID: 32171674
[TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics and Treatment Outcomes in Children, Adolescents, and Young-adults with Hodgkin's Lymphoma: a KPHOG Lymphoma Working-party, Multicenter, Retrospective Study.
Lee JM; Choi JY; Hong KT; Kang HJ; Shin HY; Baek HJ; Kook H; Kim S; Lee JW; Chung NG; Cho B; Cho SG; Park KM; Yang EJ; Lim YT; Suh JK; Kang SH; Kim H; Koh KN; Im HJ; Seo JJ; Cho HW; Ju HY; Lee JW; Yoo KH; Sung KW; Koo HH; Park KD; Hah JO; Kim MK; Han JW; Hahn SM; Lyu CJ; Shim YJ; Kim HS; Do YR; Yoo JW; Lim YJ; Jeon IS; Chueh HW; Oh SY; Choi HS; Park JE; Lee JA; Park HJ; Park BK; Kim SK; Lim JY; Park ES; Park SK; Choi EJ; Choi YB; Yoon JH;
J Korean Med Sci; 2020 Nov; 35(46):e393. PubMed ID: 33258329
[TBL] [Abstract][Full Text] [Related]
16. The prognostic impact of tumour-associated macrophages and Reed-Sternberg cells in paediatric Hodgkin lymphoma.
Gupta S; Yeh S; Chami R; Punnett A; Chung C
Eur J Cancer; 2013 Oct; 49(15):3255-61. PubMed ID: 23791542
[TBL] [Abstract][Full Text] [Related]
17. Biology of classical Hodgkin lymphoma: implications for prognosis and novel therapies.
Mottok A; Steidl C
Blood; 2018 Apr; 131(15):1654-1665. PubMed ID: 29500175
[TBL] [Abstract][Full Text] [Related]
18. From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential.
Re D; Thomas RK; Behringer K; Diehl V
Blood; 2005 Jun; 105(12):4553-60. PubMed ID: 15728122
[TBL] [Abstract][Full Text] [Related]
19. Pediatric Hodgkin Lymphoma, Version 3.2021.
Flerlage JE; Hiniker SM; Armenian S; Benya EC; Bobbey AJ; Chang V; Cooper S; Coulter DW; Cuglievan B; Hoppe BS; Isenalumhe L; Kelly K; Kersun L; Lamble AJ; Larrier NA; Magee J; Oduro K; Pacheco M; Price AP; Roberts KB; Smith CM; Sohani AR; Trovillion EM; Walling E; Xavier AC; Burns JL; Campbell M
J Natl Compr Canc Netw; 2021 Jun; 19(6):733-754. PubMed ID: 34214968
[TBL] [Abstract][Full Text] [Related]
20. Lymphomagenesis in Hodgkin lymphoma.
Matsuki E; Younes A
Semin Cancer Biol; 2015 Oct; 34():14-21. PubMed ID: 25725205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
